講演者

Marc Abrams, PhD

Chief Technology Officer & Head, US Operations

SanegeneBio

Kathryn Ackley, PhD

CMC Consultant Specializing in Oligonucleotides

Independent Consultant

Emel Adaligil, PhD

Executive Director, Chemical Biology and Peptide

Eli Lilly and Company

Padma Akkapeddi, PhD

Senior Scientist, Discovery Sciences

Denali Therapeutics

Fernando Albericio, Ph.D

Research Professor

University of Kwazulu-Natal

Seth Alexander, PhD

Director of RNA Technologies

Prime Medicine

Dr. Julia Alterman, Ph.D.

Assistant Professor, RNA Therapeutics Institute

University of Massachusetts Chan Medical

Firoz Antia, PhD

Vice President, Oligonucleotide & Small Molecule CMC

Denali Therapeutics

Dr. Ashok Bhandari, PhD

Executive Vice President, Chief Discovery Officer

Protagonist Therapeutics

Andrew Bockus

Director of Chemistry

Circle Pharma, Inc

Michael Booth

Associate Professor of Chemical Biology and Organic Chemistry

University College London

Robert Britton

Professor

Simon Fraser University

Joshua Brooks, PhD

Director, Process Sciences

Alnylam Pharmaceuticals

Linda Burkly

Executive Vice President & Chief Scientific Office

Editas Medicine

David Butler, PhD

Chief Technology Officer

Hongene Biotech Corporation

Katherine Buzecky

Director of Scientific Services

Fluid Air

Seb Caille, PhD

Senior Director

Avidity Biosciences

Judy Carmody, Ph.D.

Founder and Principal Consultant

Carmody Quality Solutions, LLC

Jill Caswell, PhD

Biology Team Leader

Almac Sciences

Pin-Nan Cheng, Ph.D

Sr Dir, Drug Substance Development, CMC

Altimmune

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Caleb Culy

Senior Principal Chemist, Process Design and Development

Eli Lilly and Company

Beatriz De La Torre, Ph.D.

Research Professor, Laboratory of Medicine and Med

University Of KwaZulu-Natal

Frank DeRosa, PhD

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence

Sanofi

Alain Deschênes

Vice President

Chemical Computing Group

Mr Mark Dickman

Professor

University of Sheffield

Amy Druschitz

Technical Business Development Manager

Croda

Vadim Dudkin, PhD

Founding Chief Technology Officer

Soufflé Therapeutics

Katie Duncan

Director

GSK

Andrzej Dziembowski

Head of the Laboratory of RNA Biology

Int'l Institute of Molecular & Cell Biology

Ms. Roxana Eggleston-Rangel

Advanced Workflows Applications Manager

Phenomenex

David Entwistle, PhD

Senior Director, Program & Pipeline Management

Codexis

Hadi Fares, PhD

Senior Scientist

DuPont Water Solutions

Maryke Fehlau

CTO

BioNukleo

Cecilia Fernández, Ph.D.

Entrepreneur in Residence

Mass General Brigham Ventures

Yannick Fillon, PhD

Product Technical Lead, Oligonucleotides

Biogen

Jennifer Franklin

Executive Director, CMC Regulatory Affairs

Ionis Pharmaceuticals

Ari Friedland

Vice President of Research

Typewriter Therapeutics

Piers Gaffney, Ph.D.

Engineering Chemist

Imperial College London

Derek Gauntlett

Vice President, Development

Codexis

Andrew Geall, PhD

Co-founder and Chief Development Officer

Replicate Bioscience

Craig Grant

Vice President and General Manager Cambridge

Veranova

Telmo Graça, PhD

Head of mRNA Process Development

Lonza

David Guay, PhD

VP Innovation & Technology

Feldan Therapeutics

Emily Guinn, PhD

Senior Engineering Advisory

Eli Lilly and Company

Takaki Habuchi, PhD

Research Associate

Nippon Shokubai

Joanna Hemming Taylor, PhD

Associate Principal Scientist

AstraZeneca

Elissa Hobert, PhD

Director of Discovery Technologies

NewCo

Greg Hoffman, PhD

Chief Scientific Officer

Deep Genomics

Dr. Cindy Hong, PhD

Associate Principal Scientist in Biocatalysis, Process Chemistry

Merck

Chunhui Huang

Senior Director and Head of Chemistry

Mariana Oncology

Stefan Hyde

Automation Manager

Asahi Kasei Bioprocess America

Aimee Jackson, PhD

Chief Scientific Officer

Atalanta Therapeutics

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Guillaume Jacquot, PhD

Program Director, Brain and Tissue Delivery of Oligonucleotides

Vect-Horus

Eckhard Jankowsky, PhD

mRNA Scientist

NewCo

Charles Johannes, PhD

Founder & President & Chief Scientist

EPOC Scientific LLC

Jace Jones, PhD

Associate Professor and Vice Chair for Education Associate Director of the Mass Spectrometry Center Department of Pharmaceutical Sciences

University of Maryland School of Pharmacy

Toshifumi Kano

Research Associate

Sumitomo Chemical Europe

Neha Kaushal, Ph.D

Associate Director, Research and Biomarkers

Sanofi mRNA Center of Excellence

Anastasia Khvorova, PhD

Professor, RNA Therapeutics Institute

UMass Chan Medical School

Ben Kleinstiver, PhD

Associate Professor

Massachusetts General Hospital & Harvard Medical School

Troels Koch, PhD

Chief Technology Officer

MiNa Therapeutics

Eric Kool, Ph.D

Professor of Chemistry

Stanford University

Michael Kopach, PhD

Associate Vice President, Synthetic Molecule Design and Development

Eli Lilly and Company

Peter Korytko, Ph.D.

President

Preclinical GPS

Andreas Kuhn, PhD

Senior Vice President RNA Biochemistry & CMC Development

BioNTech SE

Robert Langer, ScD

David H. Koch Institute Professor

Massachusetts Institute of Technology

Dr. Joe Lewcock, PhD

Chief Scientific Officer

Denali Therapeutics

Susan Li, PhD

Peptide Chief Scientist

Asymchem

Andrew Livingston

Chief Executive Officer

Exactmer

Dr. Pablo Lores Lareo, PhD

CMC Director

Sylentis

Sarah Lovelock, Ph.D.

Reader in Biological Chemistry

University of Manchester

Dr. Stefan Lutz, PhD

Chief Scientific Officer

Codexis

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Innovation and Distinguished Research Scientist

Alnylam Pharmaceuticals

Saul Martinez Montero

Senior Director and Head of Oligonucleotide Therapeutics

saul.mmontero@dyne-tx.com

Stefan McDonough, PhD

Senior Vice President, Head of Neuroscience

Atalanta Tx

John McGee

Scientific Co-Founder and Senior Vice President, Platform Technology

Parabilis Medicines

Dr. Sonja Merkas, PhD

Founder, Creator and Doer

Livinovea

Vikram Mulligan, PhD

Research Scientist

Flatiron Institute

Dr. Kiran Musunuru, MD, PhD

Barry J. Gertz Professor for Translational Research, Perelman School of Medicine

University of Pennsylvania

Jayaprakash Nair, PhD

Vice President, Research, Chemistry and Delivery Science

Alnylam Pharmaceuticals

Lubomir Nechev, PhD

Senior Vice President CMC Development

Alnylam Pharmaceuticals

Yoshitaka Nemoto

Vice President R&D

PeptiStar

Derek O'Flaherty, Ph.D

Assistant Professor

University of Guelph

Rubina Parmar,

PhD

Atlas Ventures

Walter Pebley

Chief Science Officer

OFD Life Sciences

Bradley Pentelute, PhD

Professor, Chemistry

Massachusetts Institute of Technology

Meena PhD

SVP, Translational DMPK and Clinical Pharmacology

Stoke Therapeutics

James Powell

SVP, Manufacturing and Boulder Site Head

Novo Nordisk

Roberto Profeta

R&D Manager

F.I.S. Fabbrica Italiana Sintetici

Jefferson Revell, PhD

Principal Scientist

AstraZeneca

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Tomi Sawyer, PhD

Chief Medicinal Chemistry & Peptide Drug Hunter, Courage Terapeutics; Chief Drug Hunter & President

Maestro Therapeutics

Felix Schumacher

Program Leader Targeted Therapeutics

Roche

Kevin Seibert, PhD

Vice President, Engineering, Synthetic Molecule Design and Development

Eli Lilly and Company

Laura Sepp-Lorenzino, PhD

Biotech Executive, Board Member and Industry Advisor

GNMmeds LLC

Punit Seth, PhD

SVP, Research

Alnylam Pharmaceuticals

Trishul Shah, M.S.

Global Sales and Marketing (interim), Head of Sales, Americas

PolyPeptide Laboratories Inc.

Viorel Simion, Ph.D

Director of Immunology

Sail Biomedicines

Lucas Siow

CEO and Co-Founder

ProteinQure

Mangala Soundar

VP Biology

Judo Bio

Ved Srivastava, PhD

CTO

Perpetual Medicines

G. Susan Srivatsa, PhD

President

ElixinPharma

Hannes Stärk

PhD Student, CSAIL

MIT

Lori Troup

Director of Analytical Development

Dicerna/Novo Nordisk

Uyanga Tsedev

Founder & Chief Scientific Officer

Gensaic

Bharath Venkatram

Senior Engineer, Process Development & Scale Up La

Amgen

Kurt Vesterager Gothelf, Ph.D.

Professor, Department of Chemistry and iNANO

Aarhus University

Matteo Villain, PhD

Vice President of Peptide and Oligonucleotide

Veranova

David Vodak, PhD

Chief Scientific Officer

Bend Bioscience

Thomas Vrucina

Deputy Head Liposome Technology

Polymun Scientific

Liqun Wang, PhD

Principal Scientist, Brain Targeting Program

Wyss Institute at Harvard University

Sven Warhaut, PhD

Vice Head of Manufacturing

BioSpring GmbH

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Fran Wincott, PhD

President

Wincott & Associates, LLC

Karl Dane Wittrup, Ph.D.

C.P. Dubbs Professor in Chemical Engineering and Biological Engineering

Massachusetts Institute of Technology

Steven Wolk, PhD

President

Siniwali Biotechnology Solutions

Yansheng Wu

Vice President, Global Head of CMC & Regulatory

Hongene Biotech Corporation, USA

Oron Yacoby Zevi

Chief Scientific Officer

Immunobel Therapeutics

Wuming Yan

Chief Scientist Oligonucleotides

Asymchem

Joo-Sung Yang

VP and Head of the New Therapeutics Business Development

Samyang Biopharm

Dr. Stefano Zanotti, PhD

SVP, Head of Neuromuscular Research

Dyne Therapeutics

Genwei Zhang, PhD

Head of Peptide Research

XtalPi

Xiao Zhou

Senior Scientist

Biogen

John Zuris, PhD

Principal

John Zuris Consulting LLC

Eivor Örnskov, Ph.D.

Principal Scientist, Pharmaceutical Sciences

AstraZeneca Gothenburg